ALPINE IMMUNE SCIENCES, INC. Proceeds from Issuance Initial Public Offering
ALPINE IMMUNE SCIENCES, INC. had Proceeds from Issuance Initial Public Offering of $78.80 million as of 2015-06-22, per its 10-Q filed 2017-07-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-07-21
- 2015-06-22: Proceeds from Issuance Initial Public Offering $78.80M.
| Period end | Proceeds from Issuance Initial Public Offering |
|---|---|
| 2015-06-22 | $78.80M 10-Q · filed 2017-07-21 |